Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sanghee Park
Observed name:
S. Park
Institution:
Korea National Institute of Health
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Samsung Medical Center,
Korea National Institute of Health,
Sungkyunkwan University
ORCID:
0009-0002-2009-1790
Observed ORCID:
0009-0002-2009-1790
OpenAlex ID:
A5010774465
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2023
·
Chuandong Geng
, Man-Chao Zhang
, et al.
·
Clinical Cancer Research
·
36
PDF
Local and Distant Effects of Caveolin-1 on Prostate Cancer Progression
2011
·
T. C. Thompson
, S. A. Tahir
, et al.
·
Springer eBooks
·
2
577P A study of the efficacy and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in NSCLC
2023
·
D. Choi
, H.A. Jung
, et al.
·
Annals of Oncology
·
1
PDF
Sources and culture methods for the isolation and cultivation of Coxiella burnetii
2026
·
Jiwon Kim
, Ik-Jun Park
, et al.
·
Frontiers in Microbiology
PDF
Supplementary Table S9 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Table S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S16 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S12 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S15 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S2 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S20 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S11 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S17 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S19 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S5 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S14 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S18 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S8 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S10 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Figure S7 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Methods S1 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
PDF
Supplementary Figure S4 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Table S1 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Supplementary Table S3 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025
·
Chuandong Geng
, Man-Chao Zhang
, et al.
Show more works
View as search
Works count:
145
Citation count:
39
H-index:
2
I10-index:
1
Year
Topic
Type